You are here

Our science / Clinical Trials / Find a Trial / NCT00768534

Study Evaluating Microbiological Analysis of Spontaneous Draining Acute Otitis Media

Back to Search Print Save as PDF Bookmark Trial

NCT00768534

Last updated on April 11, 2018
Back to Search Print Save as PDF Bookmark Trial

FOR MORE INFORMATION
Study Location
Dr. Andreas Busse
Tegernsee, Bavarian, 83684 Germany
See other locations
Contact
1-800-718-1021
[email protected]
Related Links
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Otitis Media
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
2-5 months
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

Main inclusion criteria:

- Children >= 2 months and =

- Spontaneous draining AOM =

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

exclusion criteria:

- Previous operation of the ear

- Chronic otitis media or tube placement with drainage >= 3 days

- Chronic disease/immune deficiency

NCT00768534
Pfizer
Completed
Study Evaluating Microbiological Analysis of Spontaneous Draining Acute Otitis Media

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your zip code, city, or country to find studies near you.
Advanced Search

Similar Trials

Otitis Media, Myringotomy Tube Insertion, Skin Rash, Trauma
National Trends in Otitis Media in Children Under 5 Years of Age
NCT01339546
All Genders
Otitis Media
Study Evaluating Microbiological Analysis of Spontaneous Draining Acute Otitis Media
NCT00768534
All Genders
0+
Years
Tegernsee, Bavarian
Otitis Media
Effect of Prevnar 13 on Ear Infections in Children
NCT01199016
All Genders
0+
Years
Multiple Sites
Otitis Media, Otitis Media With Effusion, Pneumococcal Infections
Study of Streptococcus Pneumoniae in Nose and Throats of Infants With Acute Otitis Media
NCT00195611
All Genders
0+
Years
Multiple Sites
Study Evaluating Microbiological Analysis of Spontaneous Draining Acute Otitis Media
Microbiological Analysis Of Spontaneous Draining Acute Otitis Media Including Serotype Distribution Of Pneumococcal Isolates
Describe the patient population and bacterial microbiology of pediatric patients presenting with spontaneous draining acute otitis media
Not Provided
Observational
Observational Model: Cohort
Time Perspective: Prospective
Not Provided
Retention:   Samples Without DNA
Description:
Middle ear fluid and anasopharyngeal swab
Non-Probability Sample
community sample
Otitis Media
Not Provided
Not Provided
Not Provided


*   Includes publications given by the data provider as well as publications
identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
2138
October 2015
October 2015   (Final data collection date for primary outcome measure)

Inclusion Criteria:

Main inclusion criteria:

  • Children >= 2 months and =< 5 years
  • Spontaneous draining AOM =< 2 days Main

Exclusion Criteria:

exclusion criteria:

  • Previous operation of the ear
  • Chronic otitis media or tube placement with drainage >= 3 days
  • Chronic disease/immune deficiency
Sexes Eligible for Study: All
2 Months to 5 Years   (Child)
No
Contact information is only displayed when the study is recruiting subjects
Germany
 
 
NCT00768534
0887X1-4454
B1841014 ( Other Identifier: Alias Study Number )
No
Not Provided
Not Provided
Pfizer
Pfizer
Not Provided
Study Director: Pfizer CT.gov Call Center Pfizer
Pfizer
October 2016

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting thte study website. To get updates and notications about this trail, sign up using the form below.

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]



Call Now